[Skip to Content]
[Skip to Content Landing]
January 9, 1954


Author Affiliations

Madison, Wis.

From the Department of Medicine, University of Wisconsin Medical School.

JAMA. 1954;154(2):114-120. doi:10.1001/jama.1954.02940360012004

In this presentation the treatment of Hodgkin's disease, the lymphoid cell type of lymphosarcoma, follicular lymphoblastoma, and reticulum cell sarcoma alone will be discussed, although it is accepted that the therapy of leukemia, particularly lymphocytic leukemia, might also be included, since the same or similar measures are often successfully employed for this disorder as well. This report is based on the management of patients treated in a lymphoma-leukemia outpatient clinic and general hospital for the past 20 years. Its purpose is to clarify, if possible, the status of therapy today for these entities and perhaps to suggest the optimal form of treatment under a variety of circumstances. When operative procedures and radiation were considered the sole successful therapy, the problem was simple; however, with newer therapeutic measures available, there may well be confusion in selecting the best treatment for the individual patient.

It is well known that when Thomas Hodgkin

First Page Preview View Large
First page PDF preview
First page PDF preview